Connect with us
In the first half of 2024, Novonesis achieved broad-based sales growth driven by Food&Health Biosolutions (6% growth to €876 million) and Planetary Health Biosolutions (8% growth...
Spain's medtech exports have surged, rising 41% since 2019 and 87% over the past decade. Key export categories include medical instruments (€354M), consumables (€297M), and orthopedic...
Valneva has partnered with LimmaTech Biologics to acquire exclusive rights to develop and market Shigella4V, a vaccine candidate against shigellosis. The agreement includes an upfront payment...
In phase 3 trials, Pfizer and BioNTech's vaccine showed strong immune responses against influenza A and COVID-19 but failed to meet key objectives for influenza B....
A U.S. judge ruled that Novartis lacked grounds to suspend the launch of MSN's generic version of Entresto but ordered a temporary production halt pending Novartis'...
Baxter plans to sell its renal business by early 2025 to reduce debt, continuing its strategy of divesting subsidiaries, including a $3.857 billion sale of Biopharma...
Eli Lilly is expanding its presence with the opening of a 346,000-square-foot facility in Boston, which will house 500 scientists and the first East Coast location...
Crown Laboratories is acquiring Revance Therapeutics to expand its presence in the beauty market, offering $6.66 per share, an 89% premium. Revance, maker of the Botox...
Teva's first-half performance in Spain exceeds annual forecasts, with 2024 growth projected at 7.5%. The company has invested over €70 million in Spain since 2008, with...
Eli Lilly's first-half 2023 revenues surged 31% to $20 billion, driven by Mounjaro's $4.9 billion in sales, dominating the company’s earnings. Trulicity, in contrast, saw a...
 |
|
 |  |
 |
|